An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

The new variant, NB.1.8.1, is also a subvariant of the Omicron variant. It has spread rapidly, and the earliest sample of ...

At the start of an unprecedented meeting of vaccine committee of the US Centers for Disease Control and Prevention, the ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Thimerosal is an ingredient that helps keep vaccines pathogen free. Health and Human Services Secretary Robert F. Kennedy Jr.

CDC advisory committee recommends thimerosal-free influenza vaccines for all adults and children, despite claims that the mercury-based preservative poses no health risks.